Cargando…
Development of a Formula to Correct Particle-Enhanced Turbidimetric Inhibition Immunoassay Values so That it More Precisely Reflects High-Performance Liquid Chromatography Values for Mycophenolic Acid
BACKGROUND: Mycophenolic acid (MPA) concentration measured by homogeneous particle-enhanced turbidimetric inhibition immunoassay (PETINA) may be overestimated due to its cross-reactivity with pharmacologically inactive MPA glucuronide (MPAG), as well as other minor metabolites, accumulated with rena...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777668/ https://www.ncbi.nlm.nih.gov/pubmed/29399626 http://dx.doi.org/10.1097/TXD.0000000000000754 |
_version_ | 1783294224513368064 |
---|---|
author | Nakano, Keiichi Iwami, Daiki Yamada, Takehiro Morita, Ken Yasuda, Keiko Shibuya, Hitoshi Kahata, Kaoru Shinohara, Nobuo Shimizu, Chikara |
author_facet | Nakano, Keiichi Iwami, Daiki Yamada, Takehiro Morita, Ken Yasuda, Keiko Shibuya, Hitoshi Kahata, Kaoru Shinohara, Nobuo Shimizu, Chikara |
author_sort | Nakano, Keiichi |
collection | PubMed |
description | BACKGROUND: Mycophenolic acid (MPA) concentration measured by homogeneous particle-enhanced turbidimetric inhibition immunoassay (PETINA) may be overestimated due to its cross-reactivity with pharmacologically inactive MPA glucuronide (MPAG), as well as other minor metabolites, accumulated with renal function impairment or co-administered cyclosporine A. In contrast, high-performance liquid chromatography (HPLC) is precise because it can exclude the cross-reactivity. In this study, we assumed HPLC values for MPA (HPLC-MPA) as a reference and aimed to develop a formula correcting PETINA values for MPA (PETINA-MPA) to more precisely reflect HPLC-MPA. METHODS: MPA trough concentrations were measured both by HPLC-UV and PETINA in 39 samples issued from 39 solid-organ transplant recipients. MPAG concentrations were also measured using HPLC UV assay. We determined the impacts of renal function and coadministered calcineurin inhibitor on concentrations of MPA and MPAG measured by HPLC. Then, we evaluated the difference between PETINA-MPA and HPLC-MPA. Finally, we develop a formula to reflect HPLC-MPA by using multilinear regression analysis. RESULTS: MPAG concentration was negatively correlated with estimated glomerular filtration rate (eGFR) (R(2) = 0.376, P < 0.001), although MPA was not correlated with eGFR. There were no significant differences in MPA or MPAG concentrations per dose between the patients who were co-administered tacrolimus versus cyclosporine A. Finally, we developed the formulas to reflect HPLC-MPA: Formula 1: Estimated MPA concentration = 0.048 + 0.798 × PETINA‐MPA Formula 2: Estimated MPA concentration = − 0.059 + 0.800 × PETINA‐MPA + 0.002 × eGFR However, there was no significant improvement in the coefficient of determination with addition of eGFR in the formula, suggesting that HPLC-MPA can be well predicted by only 1 variable, PETINA-MPA. CONCLUSIONS: This study developed a formula so that PETINA-MPA can be corrected to more precisely reflect HPLC-MPA. |
format | Online Article Text |
id | pubmed-5777668 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-57776682018-02-02 Development of a Formula to Correct Particle-Enhanced Turbidimetric Inhibition Immunoassay Values so That it More Precisely Reflects High-Performance Liquid Chromatography Values for Mycophenolic Acid Nakano, Keiichi Iwami, Daiki Yamada, Takehiro Morita, Ken Yasuda, Keiko Shibuya, Hitoshi Kahata, Kaoru Shinohara, Nobuo Shimizu, Chikara Transplant Direct Laboratory Method BACKGROUND: Mycophenolic acid (MPA) concentration measured by homogeneous particle-enhanced turbidimetric inhibition immunoassay (PETINA) may be overestimated due to its cross-reactivity with pharmacologically inactive MPA glucuronide (MPAG), as well as other minor metabolites, accumulated with renal function impairment or co-administered cyclosporine A. In contrast, high-performance liquid chromatography (HPLC) is precise because it can exclude the cross-reactivity. In this study, we assumed HPLC values for MPA (HPLC-MPA) as a reference and aimed to develop a formula correcting PETINA values for MPA (PETINA-MPA) to more precisely reflect HPLC-MPA. METHODS: MPA trough concentrations were measured both by HPLC-UV and PETINA in 39 samples issued from 39 solid-organ transplant recipients. MPAG concentrations were also measured using HPLC UV assay. We determined the impacts of renal function and coadministered calcineurin inhibitor on concentrations of MPA and MPAG measured by HPLC. Then, we evaluated the difference between PETINA-MPA and HPLC-MPA. Finally, we develop a formula to reflect HPLC-MPA by using multilinear regression analysis. RESULTS: MPAG concentration was negatively correlated with estimated glomerular filtration rate (eGFR) (R(2) = 0.376, P < 0.001), although MPA was not correlated with eGFR. There were no significant differences in MPA or MPAG concentrations per dose between the patients who were co-administered tacrolimus versus cyclosporine A. Finally, we developed the formulas to reflect HPLC-MPA: Formula 1: Estimated MPA concentration = 0.048 + 0.798 × PETINA‐MPA Formula 2: Estimated MPA concentration = − 0.059 + 0.800 × PETINA‐MPA + 0.002 × eGFR However, there was no significant improvement in the coefficient of determination with addition of eGFR in the formula, suggesting that HPLC-MPA can be well predicted by only 1 variable, PETINA-MPA. CONCLUSIONS: This study developed a formula so that PETINA-MPA can be corrected to more precisely reflect HPLC-MPA. Lippincott Williams & Wilkins 2017-12-13 /pmc/articles/PMC5777668/ /pubmed/29399626 http://dx.doi.org/10.1097/TXD.0000000000000754 Text en Copyright © 2017 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Laboratory Method Nakano, Keiichi Iwami, Daiki Yamada, Takehiro Morita, Ken Yasuda, Keiko Shibuya, Hitoshi Kahata, Kaoru Shinohara, Nobuo Shimizu, Chikara Development of a Formula to Correct Particle-Enhanced Turbidimetric Inhibition Immunoassay Values so That it More Precisely Reflects High-Performance Liquid Chromatography Values for Mycophenolic Acid |
title | Development of a Formula to Correct Particle-Enhanced Turbidimetric Inhibition Immunoassay Values so That it More Precisely Reflects High-Performance Liquid Chromatography Values for Mycophenolic Acid |
title_full | Development of a Formula to Correct Particle-Enhanced Turbidimetric Inhibition Immunoassay Values so That it More Precisely Reflects High-Performance Liquid Chromatography Values for Mycophenolic Acid |
title_fullStr | Development of a Formula to Correct Particle-Enhanced Turbidimetric Inhibition Immunoassay Values so That it More Precisely Reflects High-Performance Liquid Chromatography Values for Mycophenolic Acid |
title_full_unstemmed | Development of a Formula to Correct Particle-Enhanced Turbidimetric Inhibition Immunoassay Values so That it More Precisely Reflects High-Performance Liquid Chromatography Values for Mycophenolic Acid |
title_short | Development of a Formula to Correct Particle-Enhanced Turbidimetric Inhibition Immunoassay Values so That it More Precisely Reflects High-Performance Liquid Chromatography Values for Mycophenolic Acid |
title_sort | development of a formula to correct particle-enhanced turbidimetric inhibition immunoassay values so that it more precisely reflects high-performance liquid chromatography values for mycophenolic acid |
topic | Laboratory Method |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777668/ https://www.ncbi.nlm.nih.gov/pubmed/29399626 http://dx.doi.org/10.1097/TXD.0000000000000754 |
work_keys_str_mv | AT nakanokeiichi developmentofaformulatocorrectparticleenhancedturbidimetricinhibitionimmunoassayvaluessothatitmorepreciselyreflectshighperformanceliquidchromatographyvaluesformycophenolicacid AT iwamidaiki developmentofaformulatocorrectparticleenhancedturbidimetricinhibitionimmunoassayvaluessothatitmorepreciselyreflectshighperformanceliquidchromatographyvaluesformycophenolicacid AT yamadatakehiro developmentofaformulatocorrectparticleenhancedturbidimetricinhibitionimmunoassayvaluessothatitmorepreciselyreflectshighperformanceliquidchromatographyvaluesformycophenolicacid AT moritaken developmentofaformulatocorrectparticleenhancedturbidimetricinhibitionimmunoassayvaluessothatitmorepreciselyreflectshighperformanceliquidchromatographyvaluesformycophenolicacid AT yasudakeiko developmentofaformulatocorrectparticleenhancedturbidimetricinhibitionimmunoassayvaluessothatitmorepreciselyreflectshighperformanceliquidchromatographyvaluesformycophenolicacid AT shibuyahitoshi developmentofaformulatocorrectparticleenhancedturbidimetricinhibitionimmunoassayvaluessothatitmorepreciselyreflectshighperformanceliquidchromatographyvaluesformycophenolicacid AT kahatakaoru developmentofaformulatocorrectparticleenhancedturbidimetricinhibitionimmunoassayvaluessothatitmorepreciselyreflectshighperformanceliquidchromatographyvaluesformycophenolicacid AT shinoharanobuo developmentofaformulatocorrectparticleenhancedturbidimetricinhibitionimmunoassayvaluessothatitmorepreciselyreflectshighperformanceliquidchromatographyvaluesformycophenolicacid AT shimizuchikara developmentofaformulatocorrectparticleenhancedturbidimetricinhibitionimmunoassayvaluessothatitmorepreciselyreflectshighperformanceliquidchromatographyvaluesformycophenolicacid |